Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Mogulkoc (Izmir, Turkey), M. Tas (Izmir, Turkey), Y. Kabasakal (Izmir, Turkey), P. Bishop (Manchester, United Kingdom), S. Littnerová (Brno, Czech Republic), K. Hejduk (Brno, Czech Republic), M. Vašáková (Prague , Czech Republic). Differences between ANCA positive and negative lung fibrosis cases without vasculitis. 2242

Member's Comments

No comment yet.

Related content which might interest you: Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 p-ANCA positive Hashimoto‘s thyroiditis with interstitial pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 83s Year: 2005 Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Difference in chest HRCT findings in relation to ANCA subtypes in ANCA-associated vasculitis Source: International Congress 2019 – Granulomatous disorders: from bench to bedside Year: 2019 Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Interstitial lung disease associated with ANCA positivity: a retrospective analysis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Occurrence of ANCA positivity in persons with silicosis Source: Eur Respir J 2002; 20: Suppl. 38, 604s Year: 2002 Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Long-term outcome of 53 patients with anti-Jo-1 antibody-positive interstitial lung disease Source: International Congress 2017 – Rare diseases Year: 2017 Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Silicosis, asbestosis and ANCA positivity Source: Eur Respir J 2001; 18: Suppl. 33, 437s Year: 2001 Clinical significance of different cytokines expression in lung tissue in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002 Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan) Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002 Incidence, clinical pictures and courses of patients with MPO-ANCA positive interstitial pneumonia (IP) of unknown etiology Source: Eur Respir J 2004; 24: Suppl. 48, 505s Year: 2004 Interstitial lung disease (ILD) in association with polymyositis-dermatomyositis (PM/DM) with predominant lymphocytic alveolitis and anti-Jo-1-antibodies Source: Eur Respir J 2002; 20: Suppl. 38, 586s Year: 2002 Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema Source: Eur Respir J 2009; 33: 219-221 Year: 2009 Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Lung involvement in ANCA associated crescentic glomerulonephritis Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005